# Log in

Instruction to authors

The principal aim of the journal is to provide prompt publication of original works of high quality. The corresponding author is responsible on behalf of all authors for the submission. Manuscripts will be accepted on the understanding that they report original unpublished research from medical and allied areas, and are not under consideration for publication by another journal. All materials submitted will be subject to review by appropriate referees selected by the editorial office. The editors reserve the right to improve manuscripts on grammar and style.

Submissions should be made at http://my.ejmanager.com/jmas/. You will receive an e-mailed acknowledgment on successful submission. Prior to your online submission please ensure that the manuscript has been prepared according to the ‘instructions to authors’ of our journal.

Reporting guidelines

The International Committee of Medical Journal Editors (ICMJE) recommendations are to be followed for the research ethics, preparation and formatting of manuscripts submitted for publication to this journal.

Reporting guidelines for main study types

Randomised trials



Observational studies



Systematic reviews



Case reports



Qualitative research



Diagnostic / prognostic studies



Quality improvement studies



Economic evaluations



Animal pre-clinical studies



Study protocols



Full catalogue of reporting guidelines is available to download as a PDF: Reporting Guideline Catalogue May 2014.

  • Use of humans and experimental animals: Research carried out on humans must follow international and national regulations. When experimental animals are used, research carried out must follow internationally recognized guidelines on animal welfare, as well as local and national regulations. Additionally, a statement must be included in the Materials and methods section of the manuscript, identifying the institutional and/or licensing committee that has approved the experiments undertaken.
  • Cover letter: Summarize briefly the importance of the submitted work and give a statement that the article has neither been published nor submitted for publication elsewhere.
  • Format: Original work and review articles concerning fields of recognizable progress are accepted for evaluation. Manuscripts should be written in clear, concise English (US) and should contain all essential data in order to make the presentation clear.
  • General style: Manuscript should be typed using ‘Arial’ font size 12 with 1.5 line spacing. Title of the work, sub-titles and side headings should be presented in sentence-case letters.  Number of words (excluding tables and references) should not be more than 3000 for original and review articles, 1500 for case reports and short communications, 600 for commentaries and view point. Define abbreviations that are not standard at their first mention. Ensure consistency of abbreviations throughout the article.
  • Manuscripts: During online submission, author should enter/upload the content in various fields. (a) Title which should be concise and informative (sentence case) of the presented work; (b) short running title; (c) subject area; (d) summary/abstract which should contain concise and factual abstract (not more than 300 words). Abstract should be continuous without reference numbers or side headings; (e) keywords (a maximum of 6 keywords); (f) full names (expand initials) and affiliations of all authors including full postal address, phone number, fax number (with country and area code) and email address of the author to whom correspondence is to be sent; (g) Main manuscript which should include following sub-sections (i) Introduction; (ii) Material and methods; (iii) Results; (iv) Discussion; (v) Conflict of interest; (vi) Acknowledgments (vii) Source of funding and (viii) References. The pages should be numbered consecutively. Footnotes should not be used. Main manuscript file should not contain author names and affiliations.
  • Figures: Color illustrations are welcome; however, they should be submitted only if reproduction in color is intended. Color illustrations should be set to CMYK mode (not RGB). Figures should be submitted as .tiff or .jpeg files at a minimum resolution of 300 dpi. Figures should be clear, high contrast, and of the size they are to appear in the journal: 8.00 cm (3.15 inch) wide for a single column; 16.50 cm (6.50 inch) for a double column; maximum height 20.00 cm (7.87 inch). Symbols, numbering and lettering should be clearly legible and of the appropriate size.  Figures should be numbered like Fig1, Fig 2, etc. and should include a caption. Supply captions (not attached to the figure) separately in the manuscript, after references. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Explain all symbols and abbreviations used. Figures to be uploaded separately and not to be included in the main manuscript file.
  • Tables: Number (Arabic numerals) tables consecutively in accordance with their appearance in the text. Tables should include a short title. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Ensure that the data presented in tables do not duplicate results described elsewhere in the article. All tables should be typed using double-spacing. Tables to be included in the main manuscript file.
  • References: In the text, references should be cited in superscripts without brackets e.g. 1-3  or 1, 2 . Limit the number of references to 50 for review article, 30 for original article, 15 for case report and short communication. Citations should follow the standard form of MEDLINE and PubMed style, and the references must be numbered consecutively. Inclusive page numbers should be given. Complete author list is preferred; however, if more than 6 authors, 6 names and et al. can be used. Please provide PUBMED ID and/or DOI if available. Following are examples of order and style, which should be strictly adhered to:
    • Journal reference
      1. Parkin DM, Clayton D, Black RJ, Houslay MD, Wakelam MJO, Marshall CJ. Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer. 1996 Apr; 73(8):1006-12. DOI: 10.1038/bjc.1996.197 PMID:8611419 PMCID: PMC2075826
      2. Hazari MAH, Reddy BR, Uzma N, Kumar BS. Cognitive impairment in type 2 diabetes mellitus. Int J Diab Mellitus 2015; 3(1):19-24. DOI: 10.1016/j.ijdm.2011.01.001
    • Book reference

Entire book

  • Wenger NK, Sivarajan Froelicher E, Smith LK, Ades PA, Berra K, Blumenthal JA, Certo CME, Dattilo AM, Davis D, DeBusk RF, Drozda JP Jr, Fletcher BJ, Franklin BA, Gaston H, Greenland P, McBride PE, McGregor CGA, Oldridge NB, Piscatella JC, Rogers FJ. Cardiac rehabilitation. Rockville (MD): Agency for Health Care Policy and Research (US); 1995. 202 p.

Individual volumes of books

  • Voet D, Voet JG. Biochemistry. 3rd ed. Vol. 2, The expression and transmission of genetic information. New York: J. Wiley & Sons; c2004. p. 1107-560.

Chapter in edited book

  • Kone BC. Metabolic basis of solute transport. In: Brenner BM, Rector FC, editors. Brenner and Rector’s the kidney. 8th ed. Vol. 1. Philadelphia: Saunders Elsevier; c2008. p. 130-55.
  • Online database reference

Spandidos A, Wang X, Wang H, Seed B: Primer Bank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 38: D792-D799, 2010.

  • Online resource reference

American Diabetes Association Diabetes Basics. Available from http://www.diabetes.org/diabetes-basics/prevention/pre-diabetes/ (Last accessed on November 3, 2010).

  • Conflicts of interest and informed consent: ICMJE Conflict of interest disclosure form to be filled. The authors of all submitted manuscripts must declare in the covering letter whether they have any conflicts of interest. Additionally, all submitted manuscripts must include a statement that informed consent was obtained where necessary.
  • Proofs: It is of vital importance that authors check their manuscripts carefully before submission, because any errors will be faithfully transferred into the typeset version.
  • Reviews: Review articles may have different sections and sub-headings according to the subject matter and the author’s opinion; however, an abstract is mandatory.
  • Letters to the editor: Letters to the editor are considered for publication (subject to editing and abridgment) provided they do not contain material that has been submitted or published elsewhere. Letters in reference to a Journal article must not exceed 175 words (excluding references), and must be received within three weeks after publication of the article. Letters not related to a Journal article must not exceed 400 words (excluding references). A letter can have no more than five references and one figure or table. A letter can be signed by no more than three authors. You will be asked to include your full address, telephone number, fax number and e-mail address. Financial associations or other possible conflicts of interest must be disclosed.
  • Case report: Brief discussion of a single case with unique features not previously described. May be augmented by a second illustrative case. No more than six figures and four authors (one of whom should have been in clinical charge of the patient).
  • Commentary: Scientific and critical discussion on a disease or health related issue.
  • View point: This section intends to publish manuscripts providing short narratives of real life experiences in the medical and allied fields including during student life or internship or residency with a clear informative, educative or enlightening message. The manuscript can be authored by not more than two authors.
  • Journal charges:
    • Manuscript publication fees: Rs.3500/- for Indian authors or $70/- for foreign authors for each accepted manuscript
    • Annual subscription fees: India:- Individual: Rs.2500/-, Institutional: Rs.4000/- All other countries:- Individual: $100/-, Institutional: $150/-
  • Open access: "Open access" indicates that articles published online can be freely accessed at www.jmas.in by all users.